105 related articles for article (PubMed ID: 11236258)
1. [Blood coagulation activation in patients with ulcerative colitis].
Swiatkowski M; Grad K; Kłopocka M; Budzyński J; Zekanowska E; Kotschy M
Pol Arch Med Wewn; 2000; 103(1-2):47-51. PubMed ID: 11236258
[TBL] [Abstract][Full Text] [Related]
2. Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis.
Kume K; Yamasaki M; Tashiro M; Yoshikawa I; Otsuki M
Intern Med; 2007; 46(17):1323-9. PubMed ID: 17827828
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.
Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N
World J Gastroenterol; 2005 Dec; 11(48):7639-45. PubMed ID: 16437691
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
[TBL] [Abstract][Full Text] [Related]
5. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic imbalance in active and quiescent ulcerative colitis.
van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
[TBL] [Abstract][Full Text] [Related]
7. [Selected risk factors of thrombotic complications in patients with ulcerative colitis].
Stadnicki A; Bojko B; Myczkowska K; Witalińska-Łabuzek J
Wiad Lek; 2003; 56(7-8):341-7. PubMed ID: 14969162
[TBL] [Abstract][Full Text] [Related]
8. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
9. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
[TBL] [Abstract][Full Text] [Related]
10. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis.
van Bodegraven AA; Schoorl M; Linskens RK; Bartels PC; Tuynman HA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):413-8. PubMed ID: 11943956
[TBL] [Abstract][Full Text] [Related]
11. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
12. No evidence of activated blood coagulation in Crohn's disease.
Novacek G; Kapiotis S; Moser G; Speiser W; Gangl A; Vogelsang H
Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):963-7. PubMed ID: 9391785
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2011 Oct; 43(8):3013-7. PubMed ID: 21996213
[TBL] [Abstract][Full Text] [Related]
14. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
[TBL] [Abstract][Full Text] [Related]
16. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
17. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
[TBL] [Abstract][Full Text] [Related]
18. [Coagulation changes in inflammatory intestinal disease].
López Morante AJ; Prieto García M; Yuguero del Moral L; Sáez-Royuela F; Martín Lorente JL; Ojeda Giménez C
Rev Clin Esp; 1992 Jan; 190(1):18-21. PubMed ID: 1546196
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
20. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
Biagini D; Filippucci E; Agnelli G; Pagliaricci S
Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
